Anti-glomerular Basement Membrane Disease: What Have We Learned?

Adv Anat Pathol. 2021 Jan;28(1):59-65. doi: 10.1097/PAP.0000000000000280.

Abstract

Since the first clinicopathologic description by Ernest Goodpasture of a patient whom he considered to have died of influenza in 1919, substantial progress has been made in our knowledge of anti-glomerular basement membrane disease. This has led to a significant decrease in the morbidity and mortality associated with this disease. In this paper, we aim to review the literature that has enhanced our understanding of classic anti-glomerular basement membrane disease and its clinic-pathologic variants in the key areas of immunopathogenesis and histopathology. We also summarize varied clinical presentations and therapeutic strategies.

Publication types

  • Review

MeSH terms

  • Anti-Glomerular Basement Membrane Disease / immunology
  • Anti-Glomerular Basement Membrane Disease / pathology*
  • Autoantibodies
  • Basement Membrane / immunology*
  • Humans
  • Kidney / immunology
  • Kidney / pathology*

Substances

  • Autoantibodies